MedTrace Logo

Cognoa Autism Spectrum Disorder (ASD) Digital Therapeutic Engagement and Usability Study

NCT04326231 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-09-21

Study results available
· View outcomes & findings →

Summary

Cognoa will measure usability, engagement with the device, and changes in parent-reported socialization during a 4-week period of intervention at home with the Cognoa ASD therapeutic device.

Conditions

Interventions

DEVICE

Usability assessment of Cognoa ASD Therapeutic Device

Usability assessment of Cognoa ASD Therapeutic Device

Sponsors & Collaborators

  • Cognoa, Inc.

    lead INDUSTRY

Principal Investigators

  • Kelley Abrams, PhD · Cognoa, Inc.

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-17
Primary Completion
2020-07-31
Completion
2020-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04326231 on ClinicalTrials.gov